These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3896101)

  • 1. Enzymatic degradation of cholecystokinin in the central nervous system.
    Deschodt-Lanckman M
    Ann N Y Acad Sci; 1985; 448():87-98. PubMed ID: 3896101
    [No Abstract]   [Full Text] [Related]  

  • 2. Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8).
    Matsas R; Turner AJ; Kenny AJ
    FEBS Lett; 1984 Sep; 175(1):124-8. PubMed ID: 6090206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. II. Solubilization and separation of membrane-bound CCK-8 cleaving enzymes.
    Deschodt-Lanckman M; Bui ND; Koulischer D; Paroutaud P; Strosberg AD
    Peptides; 1983; 4(1):71-8. PubMed ID: 6306618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
    Najdovski T; Collette N; Deschodt-Lanckman M
    Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
    Zuzel KA; Rose C; Schwartz JC
    Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the conformation, enzymatic degradation, pharmacological potency, and binding properties in brain tissue of cholecystokinin-8 and new related peptides.
    Roques BP; Durieux C; Gacel G; Pélaprat D; Ruiz-Gayo M; Belleney J; Fellion E; Zajac JM; Fournié-Zaluski MC; Daugé V
    Ann N Y Acad Sci; 1985; 448():61-75. PubMed ID: 2992350
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotensin degradation by soluble and membrane-associated enzymes from the brain.
    Emson PC; Checler F; Camargo AC; Pittaway K; Williams B; Kitabgi P; Vincent JP
    Biochem Soc Trans; 1985 Feb; 13(1):53-4. PubMed ID: 3888724
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
    Deschodt-Lanckman M; Strosberg AD
    FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase.
    Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M
    Peptides; 1984; 5(3):649-51. PubMed ID: 6089150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
    Rose C; Vargas F; Silhouette B; Devaux B; Schwartz JC
    Neuropeptides; 1995 Mar; 28(3):157-60. PubMed ID: 7791959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of proteases in the keratinolytic larvae of the webbing clothes moth, Tineola bisselliella.
    Ward CW
    Comp Biochem Physiol B; 1972 May; 42(1):131-5. PubMed ID: 5075763
    [No Abstract]   [Full Text] [Related]  

  • 12. CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidase.
    Steardo L; Knight M; Tamminga CA; Barone P; Kask AM; Chase TN
    J Neurochem; 1985 Sep; 45(3):784-90. PubMed ID: 3897456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolysis of cholecystokinin by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
    Medeiros Mdos S; Turner AJ
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):247S. PubMed ID: 8224401
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation of human gastrin and CCK by endopeptidase 24.11: differential behaviour of the sulphated and unsulphated peptides.
    Pauwels S; Najdovski T; Dimaline R; Lee CM; Deschodt-Lanckman M
    Biochim Biophys Acta; 1989 Jun; 996(1-2):82-8. PubMed ID: 2736261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors.
    Fulcher IS; Matsas R; Turner AJ; Kenny AJ
    Biochem J; 1982 May; 203(2):519-22. PubMed ID: 7052059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasite proteases and antimalarial activities of protease inhibitors.
    Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
    Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme).
    Hooper NM; Kenny AJ; Turner AJ
    Biochem J; 1985 Oct; 231(2):357-61. PubMed ID: 2998348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there neuropeptide-specific peptidases?
    Turner AJ; Matsas R; Kenny AJ
    Biochem Pharmacol; 1985 May; 34(9):1347-56. PubMed ID: 2986644
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of gastrin and cholecystokinin by endopeptidase 24.11 from the pig stomach.
    Bunnett NW; Debas HT; Turner AJ; Kobayashi R; Walsh JH
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G676-84. PubMed ID: 3189556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.